Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors

Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors

Abstract Background In developing countries, children with hemophilia A (HA) with high‐titer inhibitor and poor immune tolerance induction (ITI) prognostic risk(s) cannot afford the recommended high‐ or intermediate‐dose ITI. Objectives To determine the efficacy of low‐dose ITI (plasma‐derived facto...

Full description

Bibliographic Details
Main Authors: Zekun Li, Zhenping Chen, Guoqing Liu, Xiaoling Cheng, Wanru Yao, Kun Huang, Gang Li, Yingzi Zhen, Xinyi Wu, Siyu Cai, Man‐Chiu Poon, Runhui Wu
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
hemophilia A
high‐titer inhibitor
immune tolerance induction
low‐dose
rituximab
Online Access:https://doi.org/10.1002/rth2.12562

Internet

https://doi.org/10.1002/rth2.12562

Similar Items